Vaccines
-
'Vaccine rejection is as old as vaccines themselves': Science historian Thomas Levenson on the history of germ theory and its deniersInterview Live Science spoke with author Thomas Levenson about his new book on the history of germ theory.
By Nicoletta Lanese Published
Interview -
Nearly 3 million extra deaths by 2030 could result from HIV funding cuts, study suggestsA modeling study looked at how anticipated cuts to international HIV funding would affect the rate of new cases and HIV-related deaths in low- and middle-income countries.
By Nicoletta Lanese Published
-
What are mRNA vaccines, and how do they work?mRNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there.
By Marilyn Perkins Published
6 Comments -
When will the US measles outbreak end?A public health official in Texas recently warned that the state's ongoing measles outbreak could last a year. Why are cases expected to keep rising?
By Emily Cooke Published
-
What are cancer vaccines?Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than regular vaccines intended to prevent infectious diseases, like measles or the flu.
By Marilyn Perkins Published
-
Who should get the new RSV vaccines? Here's everything you need to knowThere are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference?
By Nicoletta Lanese Last updated
-
CDC issues new guidelines for RSV vaccines, citing side-effect concernsThe CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.
By Nicoletta Lanese Published
-
How worried should we be about PFAS, the 'forever chemicals'?Recent studies suggest PFAS can pass through human skin and through the placenta. What does that mean for our health?
By Miriam Bergeret Published
-
New RSV shots tied to rare nervous system disorder — should you worry?There's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But health officials still recommend that this population get the shots, in consultation with their doctors.
By Stephanie Pappas Published
